Citybizlist (press release)Biogen Idec Chief George Scangos Among 25 Most Influential People in Biopharma …Citybizlist (press release)based company's "stock took off last year, fueled by positive data on key experimental therapies such as th…
In Vivo Studies Show CD137 mAb Agonist Boosts Anticancer Activity of TrastuzumabGenetic Engineering NewsRather, the CD137 agonist boosted the ability of NK cells activated using trastuzumab-coated breast cancer to kill rituximab-coated lymphoma cells. …
JIA Cancer Rates Not Linked to MedicationFamily Practice News Digital Network… TNF inhibitors (etanercept, infliximab, or adalimumab); and other immunomodulatory agents (abatacept, alefacept, anakinra, azathioprine, cyclophosphamide, cyclosporine, ef…
Helmut-Bauer-Nachwuchspreis 2011 für Multiple-Sklerose-ForschungDMSG Multiple Sklerose NachrichtenDie Arbeit von Dr. Simone Wüst wurde prämiert, weil sie im Detail die Wirkung des monoklonalen Antikörpers Daclizumab bei der T-Zellaktivierung Der 23…
Splenic Lymphomas: Is There Still a Role for Splenectomy?Cancer NetworkIncreasing experience with rituximab (Rituxan), however, suggests that it may be reasonable to reconsider the role of splenectomy as frontline therapy for SMZL. Ultimately, the prac…
ImmunoCellular And Cancer Treatment's Next FrontierSeeking AlphaRituximab, (sold under the trade names Rituxan and MabThera) and developed and marketed by Biogen Idec (BIIB) has also garnered success in the treatment of many forms of leukemia and l…
George Scangos – The 25 most influential people in biopharma todayFierceBiotechThe Weston, MA-based company's stock took off last year, fueled by positive data on key experimental therapies such as the multiple sclerosis pill BG-12 and the long-act…
MMRGlobal Goes Into 2012 Highlighting $43 Million in Projected Revenues From …MarketWatch (press release)… has more than 40 patents issued, pending and or applied for worldwide, including patents pertaining to the Company's FavId(R)/Specifid(TM…
BiovaxID® Personalized Lymphoma Vaccine is Featured in Article Published in …EON: Enhanced Online News (press release)According to the article, “This vaccine (BiovaxID) opens new doors because, as great a drug as rituximab is, even in combination …
BiovaxID(R) Personalized Lymphoma Vaccine is Featured in Article Published in …MarketWatch (press release)According to the article, "This vaccine (BiovaxID) opens new doors because, as great a drug as rituximab is, even in combination with chemo…